Thomas Krummenerl

803 total citations
4 papers, 425 citations indexed

About

Thomas Krummenerl is a scholar working on Genetics, Immunology and Molecular Biology. According to data from OpenAlex, Thomas Krummenerl has authored 4 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Genetics, 3 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Thomas Krummenerl's work include Inflammatory Bowel Disease (3 papers), Probiotics and Fermented Foods (1 paper) and Cell Adhesion Molecules Research (1 paper). Thomas Krummenerl is often cited by papers focused on Inflammatory Bowel Disease (3 papers), Probiotics and Fermented Foods (1 paper) and Cell Adhesion Molecules Research (1 paper). Thomas Krummenerl collaborates with scholars based in Germany, Australia and Ireland. Thomas Krummenerl's co-authors include Corinna Wolff, Harald Matthes, Jürgen P. Schulze, Andreas Raedler, Wolfgang Kruis, Herbert Lochs, Eckhart G. Hahn, H Malchow, Gerhard Steinmann and Stefan Schreiber and has published in prestigious journals such as Gastroenterology, The American Journal of Gastroenterology and Inflammatory Bowel Diseases.

In The Last Decade

Thomas Krummenerl

4 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Krummenerl Germany 4 265 150 129 128 71 4 425
J. Landy United Kingdom 9 129 0.5× 160 1.1× 112 0.9× 110 0.9× 75 1.1× 19 396
S C Knight United Kingdom 5 132 0.5× 205 1.4× 76 0.6× 314 2.5× 57 0.8× 13 634
Keren M. Rabinowitz Israel 10 188 0.7× 165 1.1× 113 0.9× 102 0.8× 65 0.9× 22 401
Renata Curciarello Argentina 14 162 0.6× 125 0.8× 73 0.6× 155 1.2× 106 1.5× 25 474
Harmale Tiwana United Kingdom 16 121 0.5× 174 1.2× 93 0.7× 201 1.6× 22 0.3× 23 613
Jason Catanzaro United States 8 91 0.3× 193 1.3× 73 0.6× 207 1.6× 42 0.6× 11 432
Heather Evans‐Marin United States 8 90 0.3× 232 1.5× 52 0.4× 229 1.8× 41 0.6× 11 509
Richa Chibbar Canada 9 80 0.3× 114 0.8× 73 0.6× 32 0.3× 45 0.6× 15 306
Derek Patel United States 9 105 0.4× 135 0.9× 114 0.9× 74 0.6× 49 0.7× 14 383
Hilde Nevens Belgium 3 321 1.2× 87 0.6× 188 1.5× 107 0.8× 173 2.4× 3 460

Countries citing papers authored by Thomas Krummenerl

Since Specialization
Citations

This map shows the geographic impact of Thomas Krummenerl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Krummenerl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Krummenerl more than expected).

Fields of papers citing papers by Thomas Krummenerl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Krummenerl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Krummenerl. The network helps show where Thomas Krummenerl may publish in the future.

Co-authorship network of co-authors of Thomas Krummenerl

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Krummenerl. A scholar is included among the top collaborators of Thomas Krummenerl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Krummenerl. Thomas Krummenerl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Däbritz, Jan, Jost Langhorst, Andreas Lügering, et al.. (2013). Improving Relapse Prediction in Inflammatory Bowel Disease by Neutrophil-Derived S100A12. Inflammatory Bowel Diseases. 19(6). 1130–1138. 61 indexed citations
2.
Matthes, Harald, et al.. (2010). Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN). BMC Complementary and Alternative Medicine. 10(1). 13–13. 158 indexed citations
3.
Herrlinger, Klaus, Andreas Raedler, Bernd Bokemeyer, et al.. (2005). Randomized, Double Blind Controlled Trial of Subcutaneous Recombinant Human Interleukin-11 Versus Prednisolone in Active Crohn's Disease. The American Journal of Gastroenterology. 101(4). 793–797. 62 indexed citations
4.
Schreiber, Stefan, Susanna Nikolaus, H Malchow, et al.. (2001). Absence of efficacy of subcutaneous antisense ICAM-1 treatment of chronic active Crohn's disease. Gastroenterology. 120(6). 1339–1346. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026